TRAW: SEC Form S-1 filed by Traws Pharma Inc.
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for TRAW
Across the 16 sessions after earlier TRAW headlines, the stock closed higher 5 times and lower 11 times, with a median move of 15.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | TRAW | SPY |
|---|---|---|---|
| Aug 17, 2026 | Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights | -5.4% | -0.5% |
| Jun 22, 2026 | Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program | +4.9% | -0.3% |
| Jun 15, 2026 | Traws Pharma downgraded by Ladenburg Thalmannand 1 other headline that session | -41.0% | +1.8% |
| May 27, 2026 | Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks | -3.2% | -0.0% |
| May 15, 2026 | Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results | +15.3% | -1.2% |
| May 8, 2026 | Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections | +28.2% | +0.8% |
Quantisnow market dataNASDAQ
TRAW
Traws Pharma Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2013
Get push alerts for TRAW
Full TRAW profile on Quantisnow Follow TRAW and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time